New Drug Application

Bristol Myers Squibb Q3 revenue soars 8%, new drug approved

InhaleRx clinches $38.5M funding to boost key clinical trials

Ascendis Pharma's TransCon CNP shines in ApproaCH trial results

Ionis Pharmaceuticals shares drop following equity raise

Iterum's (NASDAQ:ITRM) NDA for oral antibiotic to be reviewed by FDA advisory committee

FDA nods at Verona Pharma (NASDAQ:VRNA) COPD drug, eyes 2024 launch

Botanix Pharmaceuticals (ASX:BOT) gets FDA nod for Sofdra NDA resubmission plan